Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Epstein

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The American Journal of Geriatric Cardiology|June 21, 2001
The Growing Role of Calcium Antagonists in Treating Hypertension in the ElderlyMurray Epstein
Nature Clinical Practice. Nephrology|August 26, 2006
Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathyMurray Epstein
Kidney International Supplements|January 25, 2019
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arenaMurray Epstein
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Hyperkalemia as a constraint to therapy with combination Renin-Angiotensin system blockade: the elephant in the roomMurray Epstein
European Heart Journal|April 23, 2020
Norman K. Hollenberg, MD PhD (1936-2020)Murray Epstein
Ebiomedicine|March 17, 2016
Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the DotsMurray Epstein
European Heart Journal|August 1, 2020
Avoiding the termination of ACTTMurray Epstein
Kidney International Supplements|January 25, 2019
Hyperkalemia: current concepts and emerging therapeutic optionsMurray Epstein
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
John P. Merrill: the father of nephrology as a specialtyMurray Epstein
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Resistant hypertension: prevalence and evolving conceptsMurray Epstein
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The American Journal of Geriatric Cardiology|June 21, 2001
The Growing Role of Calcium Antagonists in Treating Hypertension in the ElderlyMurray Epstein
Nature Clinical Practice. Nephrology|August 26, 2006
Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathyMurray Epstein
Kidney International Supplements|January 25, 2019
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arenaMurray Epstein
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Hyperkalemia as a constraint to therapy with combination Renin-Angiotensin system blockade: the elephant in the roomMurray Epstein
European Heart Journal|April 23, 2020
Norman K. Hollenberg, MD PhD (1936-2020)Murray Epstein
Ebiomedicine|March 17, 2016
Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the DotsMurray Epstein
European Heart Journal|August 1, 2020
Avoiding the termination of ACTTMurray Epstein
Kidney International Supplements|January 25, 2019
Hyperkalemia: current concepts and emerging therapeutic optionsMurray Epstein
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
John P. Merrill: the father of nephrology as a specialtyMurray Epstein
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Resistant hypertension: prevalence and evolving conceptsMurray Epstein
Pageof 8